Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism - PubMed (original) (raw)

. 1985 Jan;232(1):258-62.

PMID: 3917507

Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism

C K Atal et al. J Pharmacol Exp Ther. 1985 Jan.

Abstract

Piperine, a major active component of black and long peppers, has been reported to enhance drug bioavailability. The present studies were aimed at understanding the interaction of piperine with enzymatic drug biotransforming reactions in hepatic tissue in vitro and in vivo. Piperine inhibited arylhydrocarbon hydroxylation, ethylmorphine-N-demethylation, 7-ethoxycoumarin-O-deethylation and 3-hydroxy-benzo(a)pyrene glucuronidation in rat postmitochondrial supernatant in vitro in a dose-dependent manner. Piperine inhibition of these reactions in postmitochondrial supernatant from 3-methylcholanthrene- and phenobarbital-treated rats was similar to the controls. Inhibition by piperine of arylhydrocarbon hydroxylase (AHH) from 3-methylcholanthrene-treated rats was comparable to that observed with 7,8-benzoflavone. Piperine caused noncompetitive inhibition of hepatic microsomal AHH from the untreated and 3-methylcholanthrene-treated rats with a Ki of 30 microM which was close to the apparent Km of AHH observed in the controls. Similarly, the kinetics of inhibition of ethylmorphine-N-demethylase from control rat liver microsomes exhibited noncompetitive inhibition with an apparent Km of 0.8 mM and Ki of 35 microM. These studies demonstrated that piperine is a nonspecific inhibitor of drug metabolism which shows little discrimination between different cytochrome P-450 forms. Oral administration of piperine in rats strongly inhibited the hepatic AHH and UDP-glucuronyltransferase activities. The maximal inhibition of AHH observed within 1 hr restored to normal value in 6 hr. Pretreatment with piperine prolonged hexobarbital sleeping time and zoxazolamine paralysis time in mice at half the dose of SKF-525A. These results demonstrate that piperine is a potent inhibitor of drug metabolism.

PubMed Disclaimer

Cited by

Predicting Food-Drug Interactions between Piperine and CYP3A4 Substrate Drugs Using PBPK Modeling.
Lin F, Hu Y, Zhang Y, Zhao L, Zhong D, Liu J. Lin F, et al. Int J Mol Sci. 2024 Oct 11;25(20):10955. doi: 10.3390/ijms252010955. Int J Mol Sci. 2024. PMID: 39456737 Free PMC article.
Phytochemicals and Their Usefulness in the Maintenance of Health.
Rodríguez-Negrete EV, Morales-González Á, Madrigal-Santillán EO, Sánchez-Reyes K, Álvarez-González I, Madrigal-Bujaidar E, Valadez-Vega C, Chamorro-Cevallos G, Garcia-Melo LF, Morales-González JA. Rodríguez-Negrete EV, et al. Plants (Basel). 2024 Feb 15;13(4):523. doi: 10.3390/plants13040523. Plants (Basel). 2024. PMID: 38498532 Free PMC article. Review.
Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines.
Qiu C, Zhang JZ, Wu B, Xu CC, Pang HH, Tu QC, Lu YQ, Guo QY, Xia F, Wang JG. Qiu C, et al. J Nanobiotechnology. 2023 Nov 29;21(1):456. doi: 10.1186/s12951-023-02165-x. J Nanobiotechnology. 2023. PMID: 38017573 Free PMC article. Review.
Hepatoprotective and Antioxidant Effects of Nanopiperine against Cypermethrin via Mitigation of Oxidative Stress, Inflammations and Gene Expression Using qRT-PCR.
Hussain S, Jali AM, Alshahrani S, Khairat KHM, Siddiqui R, Alam MI, Ali R, Mohammed M, Khan A, Al Shahi H, Hanbashi A, Qadri M, Ashafaq M. Hussain S, et al. Int J Mol Sci. 2023 Oct 19;24(20):15361. doi: 10.3390/ijms242015361. Int J Mol Sci. 2023. PMID: 37895045 Free PMC article.
Pharmacological Mechanisms and Clinical Applications of Curcumin: Update.
Hao M, Chu Y, Lei J, Yao Z, Wang P, Chen Z, Wang K, Sang X, Han X, Wang L, Cao G. Hao M, et al. Aging Dis. 2023 Jun 1;14(3):716-749. doi: 10.14336/AD.2022.1101. Aging Dis. 2023. PMID: 37191432 Free PMC article. Review.

Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism - PubMed (original) (raw)